Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38084
CAS Number:
70476-82-3
Dihidrocloruro de mitoxantrona
Purity:
≥ 97 % (HPLC)
Synonym(s):
Clorhidrato de 1,4-dihidroxi-5,8-bis[[2-[(2-hidroxietil)amino]etil]amino]antraquinona, Clorhidrato de 1,4-dihidroxi-5,8-bis[[2-[(2-hidroxietil)amino]etil]amino]antraceno-9,10-diona
Documents
$101.45 /25 mg
Tamaño
Request Bulk Quote
Información del producto

Mitoxantrone dihydrochloride is a potent anthracenedione derivative primarily utilized in the treatment of various cancers, including leukemia and prostate cancer. This compound exhibits unique properties that enhance its efficacy as a chemotherapeutic agent, making it a valuable choice in oncology. Its mechanism of action involves intercalating DNA, which disrupts the replication process and ultimately leads to cell death. Researchers and healthcare professionals appreciate Mitoxantrone dihydrochloride for its ability to target rapidly dividing cells, providing a strategic advantage in cancer treatment protocols.

In addition to its primary applications in cancer therapy, Mitoxantrone dihydrochloride has shown promise in treating multiple sclerosis, where it helps to reduce the frequency of relapses. Its dual functionality in oncology and neurology underscores its versatility and relevance in modern medicine. With a favorable safety profile compared to other chemotherapeutics, this compound is an essential tool for healthcare providers aiming to improve patient outcomes in challenging therapeutic areas.

Número CAS
70476-82-3
Fórmula molecular
C22H28N4O6 · 2HCl
Peso molecular
517.4
Número MDL
MFCD00242943
Punto de fusión
267 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
70476-82-3
Fórmula molecular
C22H28N4O6 · 2HCl
Peso molecular
517.4
Número MDL
MFCD00242943
Punto de fusión
267 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Mitoxantrone dihydrochloride is widely utilized in research focused on:

  • Cancer Treatment: This compound is primarily used in oncology as a chemotherapy agent for treating various types of cancer, including breast cancer and leukemia. Its ability to intercalate DNA helps inhibit cancer cell growth.
  • Multiple Sclerosis Therapy: It is also prescribed for patients with multiple sclerosis, providing benefits by reducing the frequency of relapses and slowing disease progression.
  • Research in Drug Development: Scientists use this compound in laboratory settings to study its effects and mechanisms, aiding in the development of new cancer therapies and improving existing treatment protocols.
  • Combination Therapy: Mitoxantrone dihydrochloride is often used in combination with other chemotherapeutic agents, enhancing treatment efficacy while potentially reducing side effects compared to monotherapy.
  • Targeted Drug Delivery Systems: Researchers are exploring its use in novel drug delivery systems, which can improve the targeting of cancer cells while minimizing damage to healthy tissues, thus increasing treatment safety and effectiveness.

Citas